CN105754952A - Anti-sheeppox virus K3L protein C-terminal monoclonal antibody and application thereof - Google Patents
Anti-sheeppox virus K3L protein C-terminal monoclonal antibody and application thereof Download PDFInfo
- Publication number
- CN105754952A CN105754952A CN201610087201.9A CN201610087201A CN105754952A CN 105754952 A CN105754952 A CN 105754952A CN 201610087201 A CN201610087201 A CN 201610087201A CN 105754952 A CN105754952 A CN 105754952A
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- protein
- virus
- hybridoma cell
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
Abstract
The invention discloses a hybridoma cell line capable of secreting an anti-sheeppox virus K3L protein C-terminal monoclonal antibody, the anti-sheeppox virus K3L holoprotein monoclonal antibody secreted by the hybridoma cell line as well as application of the hybridoma cell line and the antibody. The preservation number of a hybridoma cell line K3L35 capable of secreting the anti-sheeppox virus K3L protein C-terminal monoclonal antibody in China Center for Type Culture Collection (CCTCC) is CCTCC NO: C2015223. The K3L protein C-terminal monoclonal antibody can be secreted by the hybridoma cell line K3L35. The hybridoma cell line K3L35 and the monoclonal antibody secreted by the hybridoma cell line K3L35 can be applied in preparation of a reagent for diagnosing or detecting sheeppox virus infection or a reagent for experiments.
Description
Technical field
The present invention relates to strain monoclonal antibody and an application, relate to the C-terminal monoclonal antibody of a kind of anti-capripox virus K3L albumen secreting the hybridoma cell strain of monoclonal antibody of anti-capripox virus K3L PROTEIN C end, its secretion and the application of this hybridoma cell strain and antibody exactly.
Background technology
Sheep pox is a kind of high degree in contact and have crushing virosis in sheep epidemic disease, is classified as the animal epidemic of statutory report by OIE (OIE), with the variola of heating, conjunctivitis, rhinitis, skin and mucosa, dyspnea and death for feature.Sheep pox Major Epidemic in Africa, the Middle East, the more osmanli areas of India, Nepal, domestic Major Epidemic in Qinghai, Gansu, the area such as Hunan and Inner Mongol.Capripox virus (Sheeppoxvirus, SPV) Poxviridae, Chorodopoxvirinae, Capripoxvirus are belonged to, propagate mainly through aerosol, close contact or sting, sheep is the host that sheep pox virus is main, each age group all can infect, but death takes place mostly in lamb, and mortality rate is up to 100%, great economic loss is caused, it is believed that be economically potential biological weapons to sheep husbandry.Therefore, the diagnosis of sheep pox and prevention and control are always up the focus of research.
Chinese invention patent 2011103869424 discloses a kind of Capripoxvirus virus, including the chip-detecting apparatus of goat capripoxvirus, sheep pox virus and cattle lumpy skin disease virus.The goat capripoxvirus of Capripoxvirus, sheep pox virus and cattle lumpy skin disease virus, by designing specific probe, can be identified by this patent simultaneously.It is contemplated that the laborsaving and method that is prone to the micro-array chip detection Capripoxvirus goat capripoxvirus of observed result, sheep pox virus and cattle lumpy skin disease virus when setting up a kind of highly sensitive, high specificity, joint.
Chinese invention patent application 2013105940610 and 201310594930X individually disclose the gold colloidal for capripox virus gold-immunochromatographyreagent reagent for assay bar, gold labeling antibody and preparation method thereof.Adopting the optimum labelled amount of capripox virus P32 monoclonal antibody in described gold colloidal, prepared gold labeling antibody complex is scanned maximum absworption peak occur in visible-range.
These methods above-mentioned are both for the nucleic acid of virus replication intermediary and later stages or structural protein and set up, and therefore, they just can only can detect whether virus exists after the time that viral infection host 12h is even longer.And the application that the C-terminal monoclonal antibody of the anti-K3L albumen prepared by the present invention is in capripox virus early infection detects, the expression of K3L within 2 hours, can be detected the earliest at virus infected cell, within 24 hours, reach maximum.Therefore, the preparation of the K3L antibody that the present invention relates to can capripox virus early stage detectable or test kit in application.
Summary of the invention
The present invention provides the monoclonal antibody of the anti-capripox virus K3L albumen of a kind of hybridoma cell strain secreting anti-capripox virus K3L PROTEIN C terminal monoclonal antibody and secretion thereof, provides its purposes simultaneously.
The hybridoma cell strain K3L35 secreting anti-capripox virus K3L PROTEIN C terminal monoclonal antibody of the present invention is in December in 2015 the China typical culture collection center preservation in Wuhan University of Wuhan, China city on the 17th, and deposit number is: CCTCCNO:C2015223.
K3L PROTEIN C terminal monoclonal antibody can be secreted by described K3L35 hybridoma cell strain.
The K3L35 hybridoma cell strain of the present invention and secreted monoclonal antibody can infect the application in reagent in preparation diagnosis or detection capripox virus, it is possible to the application in preparation test reagent.
The method for preparing monoclonal antibody of the anti-K3L PROTEIN C end of the present invention is as follows:
Owing in capripox virus K3L gene, G/C content is significantly high, grope to find through early stage, acquisition K3L soluble protein can not be expressed by the gene of conventional method Direct Cloning capripox virus.Therefore, the present invention is according to SPVK3L gene order, K3L gene complete sequence is synthesized after carrying out codon preference analysis and codon optimized transformation, after being connected with pUC57 carrier, product will be connected again convert to DH5 α competent cell, extract plasmid and check order, by recombiant plasmid called after pUC57-K3L correct for order-checking.By in K3L gene sub-clone to prokaryotic expression carrier pET11d, recombiant plasmid called after pET11d-K3L, again by recombinant plasmid transformed to BL21(DE3) in plysS competent cell, for derivant, recombinant bacterium is carried out abduction delivering with IPTG, obtain restructuring K3L soluble protein, by collecting supernatant after great expression, carry out collection and the process of albumen, obtain protein immunization Balb/c mice the most at last, and undertaken merging hybridization by the spleen collection separation splenocyte of mice and ready SP2/0 cell, after the selectivity of cell fusion with hybridoma is cultivated, carry out the screening of hybridoma and the cloning of hybridoma, the monoclonal antibody of the present invention is obtained after the CHARACTERISTICS IDENTIFICATION of the monoclonal antibody that freeze-stored cell carrying out obtains.
K3L is as one of the Hrf of poxvirus, and its immunomodulatory gene function is always up the study hotspot of this area.Within 2002, Langland is by after building K3L and E3L gene VACV deleted strain, find that the virus of K3L gene delection can replicate on Vero, but can not replicate on bhk cell, and the virus of E3L gene delection can replicate on bhk cell, but can not replicate in Hela cell, thus demonstrating K3L and E3L is the VACV host range factor (Langlandetal., 2002).Correlational study finds, K3L comprises two functional areas, the Z-DNA calmodulin binding domain CaM of N-terminal, and rna editing enzyme (ADAR) homology, pathogenic relevant with virus.The K3LN terminal deletion virus of VACV effectively can replicate on nasal mucosa, but can not be transferred to lung or brain from nasal cavity, is substantially reduced the virus pathogenicity (Kimetal., 2009) to host；The C-terminal of K3L gene has dsRNA binding domain, it is suppressed that the activity of PKR.K3L and the eIF2a homology of VACV, it can be simulated eIF2a and suppress the phosphorylation of eIF2a in conjunction with PKR, thus the signal path of interference cell IFN antiviral.
The C-terminal monoclonal antibody of the anti-K3L albumen prepared by the present invention infects and the application in immune Research at capripox virus, it is possible to the application in preparing capripox virus detectable or test kit.In the prevention and control process of infectious disease, the detection carrying out early stage if any a certain specific molecular for cause of disease can bring great convenience for the formulation of the prevention and control measure in later stage, brings benefit for reducing being propagated further of disease.The diagnosis of current capripox virus is mainly to clinical sample and cell culture pcr analysis.And the serological method reported for work at present, it is mainly setting up of capripox virus expressing gene in late period, as always cherished the memory of based on structural protein P32(king, 2011, China's animal and veterinary, 38(9): 101-105), its detection being mainly used in the viral infection later stage (such as more than cell infection 48h) and diagnosis.And the application that the monoclonal antibody of the anti-K3L albumen prepared by the present invention is in capripox virus early infection detects, the expression of K3L within 2 hours, can be detected the earliest at virus infected cell, within 24 hours, reach maximum.Therefore, the preparation of the K3L antibody that the present invention relates to can capripox virus early stage detectable or test kit in application.
Accompanying drawing explanation
The codon Mass Distribution G/C content figure that Fig. 1 is SPVK3L before codon optimized.
The codon Mass Distribution G/C content figure that Fig. 2 is SPVK3L after codon optimized.
The quality distribution diagram of a certain position of codon that Fig. 3 is SPVK3L to be used before codon optimized.
The codon that Fig. 4 is SPVK3L to be used after codon optimized is at the quality distribution diagram with accompanying drawing 3 same position.
Fig. 5 is SPVK3L codon G/C content scattergram before optimization.
Fig. 6 is SPVK3L codon G/C content scattergram after optimization.
Fig. 7 is the electrophoretogram after restructuring pUC57-K3L carrier cloning primer carries out pcr amplification.
Fig. 8 respectively Fig. 5 pUC57-K3L and pET11d-K3L carries out the electrophoretogram after double digestion, wherein: figure A is 5pUC57-K3L；Figure B is pET11d-K3L.
Fig. 9 is pET11d-K3L sequence result.
Figure 10 is the SDS-PAGE analytical electrophoresis figure of SPVK3L protein expression.
Figure 11 is the electrophoretogram after the purification of K3L recombiant protein.
Figure 12 is the K3L recombiant protein figure after WesternBlot analyzes purification.
Figure 13 is that K3LC end monoclonal antibody is through MouseMonoclonalAntibodyIsotypingKit testing result.
Figure 14 is the mass spectrum of the C-terminal synthetic peptide of K3L.
Figure 15 is the mass spectrum of the N-terminal synthetic peptide of K3L.
Figure 16 WesternBlot identifies the electrophoretogram of monoclonal antibody.
Figure 17 is that after cell inoculation capripox virus, different time points detection K3L expresses spirogram.
Figure 18 is the immunofluorescence analysis figure of the K3L protein localization that display is detected in cell capripox virus.
Figure 19 is the immunofluorescence analysis figure after the DAPI dyeing that nucleus is carried out.
Figure 20 is the immunofluorescence analysis figure after the overlapping of Figure 18 and 19.
Detailed description of the invention
The present invention explains orally below in conjunction with embodiment.Herein below is merely to illustrate the related content details of the present invention, should not be construed as limiting the scope of the present invention.
In following example:
1. strain and cell
Strain system used in the present invention sheep pox virus Gu wave strain, the Vero cell used and SP2/0 cell preserve by applicant (Lanzhou Veterinary Inst., Chinese Acedemy of Agaricultural Sciences).
2. main agents
PUC57 cloning vehicle, Top10 competent cell, plasmid extraction kit, Xba I and BamH I restricted enzyme, T4DNA ligase are all purchased from Dalian treasured biological engineering company limited；DMEM culture medium, RPMI-1640 cell culture medium and hyclone are all purchased from Gibco company；Glue reclaims test kit purchased from AXYGEN company；PET11d expression vector, BL21(DE3) plysS Host Strains, His binding resin and nitrocellulose filter be purchased from Novagen company；Agar powder, peptone and yeast powder are all purchased from OXOID company；Ampicillin (AMP), IPTG, the rabbit anti goat igg of horseradish peroxidase (HRP) labelling and Freund's complete adjuvant and the equal available from Sigma of incomplete Freund's adjuvant；The mountain sheep anti-mouse igg of horseradish peroxidase (HRP) labelling is purchased from Biowrold company；Pre-dyed albumen marker, SuperSignalWestFemto chemical luminous substrate is purchased from ThermoFisher company；Exograph, developing and fixing liquid are all purchased from Kodak；The antibody ELISA detection kit of A type foot and mouth disease virus (FMDV-A), sheep of virus (ORFV) and PPR virus (PPRV) three kinds of cause of diseases is all purchased from Lanzhou Veterinary Inst., Chinese Acedemy of Agaricultural Sciences's diagnostic center；The N-terminal C-terminal synthetic peptide of K3L is raw work synthesis in Shanghai, and purity is 99%.Other reagent are domestic analytical pure.
3. key instrument
The sincere ZWY-240 constant temperature culture oscillator of intelligence, Eppendorf5417R High speed refrigerated centrifuge, Eppendorf5810R High speed refrigerated centrifuge, MastercycleEppendorfPCR instrument, the grand DNP-9052 electro-heating standing-temperature cultivator of essence, good flat JA2003 electronic balance, HealForceBIOsafe12 Biohazard Safety Equipment, the half-dried transferring film instrument of Bole.
One, the codon optimized synthesis of SPVK3L full genome, clone and qualification
According to SPVK3L gene order, after carrying out codon preference analysis and being codon optimized, synthesize complete sequence.Synthetic product, through the agarose gel electrophoresis analysis of 1%, cuts the purpose band that size is about 300bp under uviol lamp, reclaims test kit with AXYGEN company DNA gel and genes of interest is purified；Being connected overnight by 4 DEG C of sheep pox virus K3L gene PCR product and pUC57 carrier, reaction system is: DNA fragmentation 4 μ L, pUC57 carrier 1 μ L, the Solution of recovery I 5 μ L；To connect product to convert to DH5 α competent cell, 37 DEG C of quiescent culture are overnight；Being placed in the LB culture medium containing AMP resistance with the rifle point picking monoclonal bacterium colony of sterilizing, 37 DEG C of shaken cultivation are overnight；Taking 2ml overnight culture, extract recombiant plasmid according to Dalian treasured biology plasmid extraction kit description and carry out enzyme action qualification, reaction system is: pUC57-SPVK3L10 μ L, BamH I 1 μ L, Xba I 1 μ L, 10 × Kbuffer2 μ L, adds ddH2O to 20 μ L；The enzyme action of 20 μ L recombiant plasmid being identified, product is completely used for agarose gel nucleic acid electrophoresis, and electrophoresis result is analyzed by ultraviolet gel imaging system and takes pictures.As shown in Figure 8, the small fragment size after enzyme action is about 270bp to result, it was shown that SPVK3L gene is correctly inserted in pUC57 carrier.Recombiant plasmid send the order-checking of Invitrogen company identify, result shows that Insert Fragment does not correctly produce sudden change.
SPVK3L gene order before codon optimized is: SEQIDNO1；
SPVK3L gene order after codon optimized is: SEQIDNO2；
Coding SPVK3L protein sequence is: SEQIDNO3.
Through the present invention codon optimized after, codon grade improve, quality is higher, and G/C content is decreased obviously, and corresponding result is referring to accompanying drawing 1 to accompanying drawing 6.Fig. 2 showing, the ratio that the high-quality codon of codon optimized rear SPV accounts for is greatly improved than (Fig. 1) before optimizing, and in Fig. 4 display codon optimized after all of nucleotide sequence site of SPVK3L mass ratio optimize before (Fig. 3) increase, and Fig. 6 be shown that SPVK3L codon optimized after G/C content than optimize before (Fig. 5) decline to some extent.This is beneficial to K3L solubility expression in escherichia coli.
Two, the structure of SPVK3L prokaryotic expression vector
PUC57-SPVK3L recombiant plasmid correct with qualification for pET11d prokaryotic expression carrier is carried out BamH I and Xba I double digestion under 37 DEG C of water bath condition, reaction system is: pET11d/pUC57-SPVK3L10 μ L, BamH I 1 μ L, Xho I 1 μ L, 2 × Kbuffer2 μ L, adding ddH2O to 20 μ L, electrophoresis showed all has the fragment (referring to accompanying drawing 8A) of expection size；Reclaim test kit description by glue and reclaim carrier and purpose fragment, carrier and purpose fragment are attached under 16 DEG C of water bath condition, reaction system is: SPVK3L gene reclaims fragment 15 μ L, pET11d carrier recovery fragment 3 μ L, 10 × T4 ligase buffer2.5 μ L, T4DNA ligase 1 μ L adds ddH2O to 25 μ L；Product will be connected convert to BL21(DE3) plysS competent cell, 37 DEG C of shaken cultivation are overnight；Taking 2mL overnight culture, extract recombiant plasmid according to Dalian treasured biology plasmid extraction kit description and carry out enzyme action qualification, reaction system is: pET11d-SPVK3L10 μ L, BamH I 1 μ L, Xho I 1 μ L, 10 × Kbuffer2 μ L, adds ddH2O to 20 μ L；The enzyme action of 20 μ L recombiant plasmid being identified, product is completely used for agarose gel nucleic acid electrophoresis, and electrophoresis result is analyzed by ultraviolet gel imaging system and takes pictures.Small fragment size after enzyme action is about 270bp, referring to Fig. 8 B, it was shown that SPVK3L gene is correctly inserted in pET11d carrier.Recombiant plasmid send the order-checking of Invitrogen company identify, sequencing result is as it is shown in figure 9, result shows that Insert Fragment does not correctly produce sudden change.
Three, the abduction delivering of K3L gene
Take 50 μ L positive bacterium solution overnight culture to 5mLLB culture medium, when 37 DEG C of shaken cultivation are to OD600=0.6, add IPTG to final concentration of 1mM abduction delivering 4h.Drawing the bacterium solution after 1mL induction, the centrifugal 10min of 5500r/min collects thalline, adds 20 μ L5 × SDS-PAGEloadingbuffer, mix homogeneously, be placed in boiling water and process 5min, SDS-PAGE testing goal protein expression situation after adding the 80 resuspended thalline of μ LPBS.As shown in Figure 10, recombiant protein size is about 10ku to result, in the same size with expection.
Four, the antigenicity analysis of SPVK3L recombiant protein
Protein sample is after SDS-PAGE electrophoresis, and semidry method is transferred to NC film.Film is immersed in confining liquid 4 DEG C close overnight, it is primary antibodie with SPV standard positive serum respectively, the rabbit anti goat igg of HRP labelling is two anti-carry out Western-blot analysis, referring finally to ThermoFisher company SuperSignalWestFemto chemical luminous substrate operating instruction, purpose band is developed, recombiant protein is revolted originality and is analyzed.As shown in Figure 8, SPV standard positive serum is capable of identify that SPVK3L recombiant protein to result, it was shown that SPVK3L albumen can produce specific antibody by stimulating animal body, and namely SPVK3L has antigenicity, it is possible to as the detection SPV candidate albumen infected.
Five, the purification of SPVK3L recombiant protein
1mL recombinant bacterium being accessed 100ml and contains the LB culture medium of AMP resistance, 37 DEG C of shaken cultivation are to OD600=0.6, carry out abduction delivering by the expression condition optimized；The centrifugal 10min of 5500r/min collects thalline, abandons supernatant, carries out ultrasonication with after the resuspended thalline of 10mLPBS, and ultrasound procedures is: ultrasonic 5s, stops 8s；After ultrasonic, taking the centrifugal 10min of 1mL cellular lysate liquid 12000r/min, collect supernatant and precipitation respectively, precipitation is with resuspended with the PBS of supernatant same volume, and SDS-PAGE analyzes the solubility of SPVK3L recombiant protein.Respectively taking 10 μ L of supernatant and precipitation carries out PAGE gel electrophoretic analysis, as shown in Figure 10, recombiant protein major part is present among supernatant result with soluble form.Recombiant protein uses Novagen company His binding resin description to be purified, and respectively takes 10 μ L sample and carries out PAGE gel electrophoretic analysis, and as shown in figure 11, the recombiant protein band after purification is comparatively single, it does not have the pollution of other foreign proteins for result.
Six, by recombiant protein SPVK3L immunity BALB/c mouse
The BALB/c mouse choosing 6～8 week old carries out following immune programme for children: during initial immunity, and the recombiant protein SPVK3L after purifying with 100 μ g mixes with equivalent not formula Freund's complete adjuvant, subcutaneous multi-point injection after emulsifying；Head exempts from latter 14 days, mixes with incomplete Freund's adjuvant with the recombiant protein of same dose, booster immunization after emulsifying.Two exempt from latter 14 days take a blood sample and separate serum, are coated elisa plate with the 0.2 μ g recombiant protein SPVK3L purified, and carry out indirect ELISA test, measure serum titer, and the Mouse Antisera titer of result display preparation is 1:100000.
The recombiant protein SPVK3L of purification is after SDS-PAGE electrophoresis, and semidry method is transferred to NC film.Film is immersed in confining liquid 4 DEG C close overnight, Mouse Antisera with preparation is primary antibodie respectively, the mountain sheep anti-mouse igg of HRP labelling is two anti-carry out Western-blot analysis, referring finally to ThermoFisher company SuperSignalWestFemto chemical luminous substrate operating instruction, purpose band is developed, the SPVK3L albumen Mouse Antisera of preparation is identified.Result as shown in figure 12, the identification SPVK3L albumen that the Mouse Antisera of preparation can be special, it was shown that the Mouse Antisera reliable in quality of preparation, can be used for the detection of SPVK3L albumen in basic test.
Seven, cell fusion
Cell fusion is carried out after booster immunization mice 3d.After extraction eyeball of mouse takes blood, mice is put to death in dislocation, put into after 70% vial places 2min, in superclean bench, mice is fixed on cystosepiment, unties skin of abdomen and find spleen, take off with tweezers, put in 200 order rustless steel filter membranes and grind gently, rinse lower cell with PBS gently, put into the centrifugal 10min of 3000rpm in the centrifuge at 37 DEG C afterwards, standby after abandoning supernatant；When preparing feeder cells, mice is put to death in dislocation, put into after 70% vial places 2min, in superclean bench, mice is fixed on cystosepiment, untie skin of abdomen, draw PBS with syringe and inject gently under peritoneum, again the liquid containing feeder cells is washed out from another side, put into the centrifugal 10min of 3000rpm in the centrifuge at 37 DEG C afterwards, standby after abandoning supernatant.In 40 DEG C of water-bath beakers, in order to alleviate PEG2000 toxicity, slowly PEG2000 is added drop-wise in the fusion centrifuge tube of shake clockwise gently, time controls within 1min, add 1640 cell culture mediums of 20%FBS afterwards, blow afloat cell gently, cell is taped against in 6 96 empty culture plates, every hole 100 μ L.After good for culture plate labelling, put into 37 DEG C containing 5%CO2-Cell culture incubator in cultivate, selecting in cultivation 1～2 day with HAT, a large amount of oncocyte will be had dead, 3～4 days posterior tuberosity vanished cells, hybrid cell forms microcolony, and HAT selects culture fluid should use HT culture fluid instead after maintaining 7～10 days, maintain again 2 weeks, use general culture fluid instead.During above-mentioned selection is cultivated, when hybridoma is covered with 1/10 area at the bottom of hole, can start to detect specific antibody, filter out required hybridoma cell line.During selecting to cultivate, generally within every 2～3 days, change half culture fluid.
Obtained hybridoma cell line being delivered China typical culture collection center and carries out preservation, preserved material called after: hybridoma cell strain K3L35, its deposit number is CCTCCNo:C2015223.
Eight, the screening of positive hybridoma cell strain and sub-clone are cultivated
First, determine that K3L is as antigen the best package amount by Founder experiment.The K3L purifying protein of 0.5,1.0,2.0,4.0 μ g is coated 96 orifice plates, and 6 holes of each concentration are respectively set to 3 feminine genders of 3 positives.Upright titration is carried out, simultaneously using non-immunized mice negative serum as negative control with the K3L purifying protein immunized mice positive serum of different extension rates.
Being coated 96 hole elisa plates with every hole 0.5 μ g K3L albumen purified, 4 DEG C overnight；PBST washs 3-4 time, each 3-5min；Every hole adds the PBST of 5% defatted milk powder of 200 μ L, closes 2h for 37 DEG C;PBST washs 3-4 time, and each 3-5min pats dry on folding gauze；Application of sample: add measuring samples 0.1ml in reacting hole, puts 37 DEG C of incubations 1 ~ 2 hour, is washed out (doing blank well (being not added with sample), negative control hole (wild type) and Positive control wells) simultaneously.Each reacting hole adds the antibody 0.1ml of new dilution.Put 37 DEG C of incubations 1 ~ 2 hour.It is washed out.Add ELIAS secondary antibody: each reacting hole adds the enzyme labelled antibody 0.1ml of new dilution.37 DEG C of incubations 45 minutes ~ 1 hour, wash 5 times.Add substrate solution colour developing: each reacting hole adds the OPD substrate solution 0.1ml just prepared, 37 DEG C of dark place incubations 10min minute.Each reacting hole adds 2M sulphuric acid 0.05ml.Survey OD value judged result, on ELISA detector, use 492nm detection.With more than the 2.1 of negative control OD value times for positive (calculating after returning to zero with blank control wells).Pick out the hybrid tumor cell monoclonal of anti-capripox virus K3L albumen.
According to the method described above, the positive hybridoma cell that obtains of screening is carried out sub-clone, again assigns in 96 well culture plates after original hole HAT Selective agar medium being diluted by limiting dilution assay, afterwards the form of observation of cell and quantity.Adjusting cell is 3～10 cell/ml.Taking the Tissue Culture Plate of the feeder layer that the previous day prepares, every hole adds diluting cells 100 μ l.Hatch in 37 DEG C, in 5%CO2 incubator.Change liquid at the 7th day, within later every 2～3 days, change liquid 1 time.8～9 days visible cell Clone formation, detect antibody activity in time.The cell in positive hole is moved to amplification culture in 24 orifice plates.Each clone should be frozen as early as possible.
Nine, a large amount of of monoclonal antibody prepare and antibody, titration
By lumbar injection 0.5ml norphytane in 8 week old BALB/C Mus, pneumoretroperitoneum injection 1 × 10 in 2 weeks6Individual hybridoma, inoculating cell can produce ascites after 7～10 days, the health status of close observation animal and sign of ascites as, treat that ascites is many as far as possible, and before mice frequency domain death, put to death mice, sucking in test tube with dropper by ascites, a mice can obtain 5～10ml ascites.Also usable syringes extracting ascites, can collect for several times repeatedly.The ascites obtained is centrifuged 10min in 1000g, discards upper strata oils and fats and bottom precipitation, collect supernatant subpackage and-20 DEG C, measure Monoclonal Antibodies in Mice Ascites content and can reach 8mg/ml.
Ten, the biological analysis of monoclonal antibody
(1) monoclonal antibody hypotype is identified
The immunoglobulin standard subgroup identification test kit adopting Sigma company is identified, is operated referring especially to test kit description.Qualification result is shown in Figure 13, it was shown that the monoclonal antibody that the present invention obtains is IgG2b.
(2) analysis of immunogenicity (WB)
Westernblot is adopted to analyze the immunocompetence of the monoclonal antibody obtained.nullBy the C-terminal (synthesis mass spectrum is shown in Figure 14) of K3L、N-terminal synthetic peptide (synthesis mass spectrum is shown in Figure 15)、Restructuring purification K3L albumen、Cell harvesting pyrolysis product and the non-infected cells albumen loading of sheep pox virus infection 12h and 24h carry out SDS-PAGE electrophoresis，It is transferred to afterwards on NC film，Film is immersed in confining liquid 4 DEG C close overnight，The ascites of the monoclonal antibody inducing mouse of 1:100 dilution is primary antibodie respectively，The mountain sheep anti-mouse igg of HRP labelling is two anti-carry out Western-blot analysis，Referring finally to ThermoFisher company SuperSignalWestFemto chemical luminous substrate operating instruction，Purpose band is developed，The SPVK3L protein monoclonal antibody of preparation is identified.Result is as shown in figure 16, the mouse hydroperitoneum antibody of RGDV of preparation can be special identification K3LC end synthetic peptide, but N-terminal synthetic peptide can not be identified, and be capable of identify that SPVK3L albumen, show that the antibody mass of preparation is reliable, can be used for the detection of the detection of SPVK3L albumen in basic test and K3LC end.
(3) analysis of different time after K3L antibody test virus infected cell
Capripox virus is inoculated Vero cell, respectively at infecting latter 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 24 hours and 48 hr collections cell and culture fluid, then elisa plate it is coated, it is antibody with anti-capripox virus K3L protein hybridoma cell conditioned medium, the expression of K3L albumen after detection SPV infection cell, result is shown in Figure 17.Show 2 hours after capripox virus infection cell just to detect K3L albumen.Increasing over time, intensity is more and more stronger.Obvious K3L monoclonal antibody may be used for the early diagnosis that capripox virus infects.
(4) immunofluorescence analysis Subcellular Localization
By the Vero cell of capripox virus GY strain vero cells infection and matched group with the fixing 20min of paraformaldehyde of 4%, after drying at room temperature, wash 3 times with the PBS containing 0.1%Tween-20, pH7.4,10min/ time；After 5%BSA incubation 30min, the ascites of the capripox virus K3L PROTEIN C terminal monoclonal antibody inducing mouse that PBS1:100 times of addition 0.1%Tween-20, pH7.4 dilutes is primary antibodie, after acting on 1h in 37 DEG C, washs in aforementioned manners；Add the goat anti-mouse IgG antibodies of the 1:100 times of rhodamine labelling diluted, after acting on 30min in 37 DEG C, with same method washing.Finally by the glycerol mounting of 90%, fluorescence microscope result.Indirect immunofluorescene assay result is shown in Figure 18 to 20.Wherein Figure 18 is shown that being detected capripox virus expressing K 3L albumen, and 19 is the DAPI dyeing that nucleus is carried out, and Figure 20 is to the K3L observation to albumen situation after the overlapping of Figure 18 and 19.Result shows that obvious red fluorescence occurs in infected group, significantly polymerization and the place that the degree of polymerization is more high occurs by green fluorescence visible cell, and fluorescence is more strong, has fluorescence, and do not have fluorescence in nucleus in cytoplasm, it was shown that K3L mainly exists in cytoplasm.
(5) antibody specificity analysis
It is respectively adopted A type foot and mouth disease virus (FMDV-A), sheep of virus (ORFV) and PPR virus (PPRV) and tetra-kinds of cause of diseases of SPV are coated elisa plate, be that antibody detects with anti-capripox virus K3L protein hybridoma cell conditioned medium.Testing result is referring to table 1.It is shown that above-mentioned three kinds of viruses all can not react with the monoclonal antibody in the present invention, and can react with SPV.
Conclusion
By said method, can obtaining sheep pox virus restructuring K3L albumen and hyper-immune serum thereof, result shows that this albumen has good antigenicity, can as the candidate albumen of detection sheep pox virus detection；By this restructuring K3L protein immunization BALB/c mouse, the monoclonal antibody of preparation can specific recognition SPVK3L albumen, after to virus infected cell, the detection of K3L albumen volume is found by different time points, can inoculate 2 hours at cell the earliest and K3L albumen just can be detected, it was shown that it can be used in basic test the detection to SPVK3L albumen.
<110>Lanzhou Veterinary Inst., Chinese Acedemy of Agaricultural Sciences
<120>monoclonal antibody of anti-capripox virus K3L PROTEIN C end and application thereof
<160>3
<210>1
<211>267
<212>DNA
<213>the SPVK3L gene order before optimizing
<400>
atgtcatcgaatagcgatttggcattttgttacgttttacctaacattaatgaagtaaca60
gatggtattgtgtgtataagagataacattgtatatgtaaaactaattaactatggtttg120
gaagcacttgtaatagattatgttaatataaacatggatcaaatgaataatataaaaaaa180
acattagttaataaattaattaatgtgcaaattataaggatgaacaaaataaaaggatat240
attgatgtaaaaatttataataacaac267
<210>2
<211>267
<212>DNA
<213>the SPVK3L gene order after optimizing
<400>
atgtcaagtaactccgacctggcgttttgctatgtgctgccgaatatcaacgaagtcacg60
gatggtattgttttcattaaagataacattgtgtatgttaaactgatcaactacggcctg120
gaagcgctggtcattgattatgtggacatcaacatggatcagatgaacaacattaagaaa180
accctggttaacaaactgatcaatgtccaaatcgtgcgtatgaataaaatcaaaggctac240
atcgacgtgaaagtccacaataataat267
<210>3
<211>89
<212>PRT
<213>coding SPVK3L protein sequence
<400>
MetSerSerAsnSerAspLeuAlaPheCysTyrValLeuProAsn
151015
IleAsnGluValThrAspGlyIleValCysIleArgAspAsnIle
16202530
ValTyrValLysLeuIleAsnTyrGlyLeuGluAlaLeuValIle
31354045
AspTyrValAsnIleAsnMetAspGlnMetAsnAsnIleLysLys
46505560
ThrLeuValAsnLysLeuIleAsnValGlnIleIleArgMetAsn
61657075
LysIleLysGlyTyrIleAspValLysIleTyrAsnAsnAsn
76808589
Claims (6)
1. can secreting the hybridoma cell strain K3L35 of anti-capripox virus K3L PROTEIN C terminal monoclonal antibody, it at China typical culture collection center deposit number is: CCTCCNO:C2015223.
2. the monoclonal antibody of the hybridoma cell strain secretion described in claim 1.
3. the application in preparing early diagnosis reagent or early stage detection capripox virus infection reagent of the hybridoma cell strain described in claim 1.
4. the application in preparing early diagnosis or early stage detection capripox virus infection reagent of the monoclonal antibody described in claim 2.
5. the application in preparation test reagent of the hybridoma cell strain K3L35 described in claim 1.
6. the monoclonal antibody of the hybridoma cell strain K3L35 secretion described in claim 1 application in preparation test reagent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610087201.9A CN105754952B (en) | 2016-02-16 | 2016-02-16 | Monoclonal antibody of anti-capripoxvirus K3L protein C terminal and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610087201.9A CN105754952B (en) | 2016-02-16 | 2016-02-16 | Monoclonal antibody of anti-capripoxvirus K3L protein C terminal and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105754952A true CN105754952A (en) | 2016-07-13 |
| CN105754952B CN105754952B (en) | 2020-07-10 |
Family
ID=56329800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610087201.9A Active CN105754952B (en) | 2016-02-16 | 2016-02-16 | Monoclonal antibody of anti-capripoxvirus K3L protein C terminal and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105754952B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108912226A (en) * | 2018-07-27 | 2018-11-30 | 中国农业科学院兰州兽医研究所 | One kind being based on the anti-goat capripoxvirus VHH-4-2 of two-humped camel and purposes |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000062735A2 (en) * | 1999-04-15 | 2000-10-26 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| US20030044384A1 (en) * | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| US20080031886A1 (en) * | 1999-11-12 | 2008-02-07 | Oncolytics Biotech Inc. | Viruses for the treatment of cellular proliferative disorders |
| CN101802198A (en) * | 2007-07-23 | 2010-08-11 | 圣诺菲·帕斯图尔有限公司 | immunogenic polypeptides and monoclonal antibodies |
| CN102659947A (en) * | 2006-04-06 | 2012-09-12 | 协和发酵麒麟株式会社 | Novel anti-CD98 antibody |
| US20130034867A1 (en) * | 2011-08-03 | 2013-02-07 | Pierce Biotechnology, Inc. | Methods for isotopically labeling biomolecules using mammalian cell-free extracts |
-
2016
- 2016-02-16 CN CN201610087201.9A patent/CN105754952B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030044384A1 (en) * | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| WO2000062735A2 (en) * | 1999-04-15 | 2000-10-26 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| US20080031886A1 (en) * | 1999-11-12 | 2008-02-07 | Oncolytics Biotech Inc. | Viruses for the treatment of cellular proliferative disorders |
| CN102659947A (en) * | 2006-04-06 | 2012-09-12 | 协和发酵麒麟株式会社 | Novel anti-CD98 antibody |
| CN101802198A (en) * | 2007-07-23 | 2010-08-11 | 圣诺菲·帕斯图尔有限公司 | immunogenic polypeptides and monoclonal antibodies |
| US20130034867A1 (en) * | 2011-08-03 | 2013-02-07 | Pierce Biotechnology, Inc. | Methods for isotopically labeling biomolecules using mammalian cell-free extracts |
Non-Patent Citations (1)
| Title |
|---|
| 吴娜: "PKR抗羊痘病毒作用及与K3L蛋白作用关系的研究", 《 中国优秀硕士学位论文全文数据库 农业科技辑》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108912226A (en) * | 2018-07-27 | 2018-11-30 | 中国农业科学院兰州兽医研究所 | One kind being based on the anti-goat capripoxvirus VHH-4-2 of two-humped camel and purposes |
| CN108912226B (en) * | 2018-07-27 | 2020-06-09 | 中国农业科学院兰州兽医研究所 | Bactrian camel-based anti-goatpox virus VHH-4-2 and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105754952B (en) | 2020-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dong et al. | Efficacy of a formalin-killed cell vaccine against infectious spleen and kidney necrosis virus (ISKNV) and immunoproteomic analysis of its major immunogenic proteins | |
| CN109970852A (en) | Secrete hybridoma cell strain and the application of rabies poison M protein monoclonal antibody | |
| CN107058239B (en) | Anti-classical swine fever virus E2 protein monoclonal antibody cell strain and application thereof | |
| CN107056898A (en) | 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application | |
| CN106442981B (en) | A kind of 1 type antibody indirect ELISA diagnostic kit of human bocavirus | |
| Venkatesan et al. | Expression and evaluation of recombinant P32 protein based ELISA for sero-diagnostic potential of capripox in sheep and goats | |
| Kobayashi et al. | Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system | |
| CN114874995B (en) | Swine fever virus 2E rns Monoclonal antibody hybridoma cell strain of protein and application | |
| CN102690327B (en) | Enterovirus 71 neutralized epitope polypeptide and application thereof | |
| CN108614121A (en) | Bovine viral diarrhea virus E2 proteantigen multi-epitope fusogenic peptides and its preparation and application | |
| CN104211785B (en) | Duck tembusu virus E protein third-structural domain recombinant protein and use thereof | |
| CN107033226A (en) | A kind of PPR virus F protein epitope peptide and its determination, preparation method and application | |
| CN113527475B (en) | Hybridoma cell secreting novel duck reovirus sigma C protein monoclonal antibody, monoclonal antibody and application | |
| CN102533663B (en) | Foot-and-mouth disease hybridoma cell line, monoclonal antibody, detection reagent and test kit | |
| CN103539839A (en) | Neutralizing epitope peptide of enterovirus 71-type VP2 antigen and application thereof | |
| CN105695417A (en) | Hybridoma cell strain capable of secreting anti-mycoplasma bovis monoclonal antibody and application thereof | |
| CN106970210B (en) | A kind of toxoplasmosis indirect ELISA diagnostic reagent kit | |
| KR20210123234A (en) | Recombinant nucleocapsid protein for diagnosis and vaccine of COVID-19 and use thereof | |
| CN105754951A (en) | Anti-sheeppox virus K3L protein monoclonal antibody and application thereof | |
| CN106701687A (en) | Hybridoma cell strain and rabies virus phosphoprotein monoclonal antibody generated by same | |
| CN105754952A (en) | Anti-sheeppox virus K3L protein C-terminal monoclonal antibody and application thereof | |
| CN110016466B (en) | Monoclonal antibody for specifically detecting bluetongue virus, hybridoma cell strain and application thereof | |
| CN107033225A (en) | A kind of PPR virus HN Protein Epitopes peptide and its determination, preparation method and application | |
| CN113512098A (en) | Indirect ELISA (enzyme-Linked immuno sorbent assay) method for identifying swine fever virus and bovine viral diarrhea virus serum antibodies and application thereof | |
| CN110196325B (en) | In-plug virus diagnosis kit and test paper |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |